Hematology
Clinical
DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes
In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT)...
Clinical
Anticoagulation and antiplatelet therapy after GI bleed cut mortality, ischemic events
In patients who present with a gastrointestinal bleed (GIB) while on an anticoagulants (AC) or antiplatelets (AP), what are the risks and benefits...
News
Full-dose anticoagulation reduces need for life support in COVID-19
Clinical
DOACs show safety benefit in early stages of CKD
In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?
News
In COVID-19 patients, risk of bleeding rivals risk of thromboembolism
News
A 4-point thrombocytopenia score was found able to rule out suspected HIT
News
Cost is the main hurdle to broad use of caplacizumab for TTP
“If we take finances out, I think almost every patient except those with a bleeding risk or bleeding problem should get it,” an investigator said...
News
What to do when anticoagulation fails cancer patients
News
CMS launches hospital-at-home program to free up hospital capacity
The agency will be giving more flexibility to ambulatory surgery centers (ASCs) to provide hospital-level care.
News
Factor XI inhibitor–based anticoagulation strategies gain ground
“When we compare the FXI inhibitors with existing anticoagulants, we don’t necessarily want to go up against the DOACs.”